FP5Individual fellowship2002–2003
JOHN C LUKAS · Optimization of dose regimen for chronically administered drugs with population pharmacokinetic methods
FP5 — Improving Human Research Potential
- Duration
- 2002-09-01 → 2003-08-31
- EU contribution
- €76,000
- Participants
- 1
- Scheme
- RGI
Lines connect the coordinator with its partners.
Project objective
State of the art population"' pharmacokinetic analysis is used to explain and predict the interindividual variability of three costly and chronically administered immunosuppressants, antineoplasic and antiepileptic drugs."
Original text from CORDIS.
Participants
- NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS · ATHENSCoordinatorGreece
Links
Data: CORDIS, © European Union